Biohaven Announces Pricing of Initial Public Offering of Common Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Biohaven Pharmaceutical (BHVN) IPO Opens up 18%
May 4, 2017 9:57 AM EDTToday's IPO for Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) opened for trading at $20 after pricing 9,900,000 of its common shares at an initial public offering price of $17.00 per share.
In addition, Biohaven has granted the underwriters a 30-day option to purchase up to an... More
